Related Experiment Videos
Panretinal photocoagulation for radiation-induced ocular ischemia
J J Augsburger1, S E Roth, L E Magargal
1Oncology Service, Wills Eye Hospital, Philadelphia, Pennsylvania 19107.
Ophthalmic Surgery
|August 1, 1987
Summary
Panretinal photocoagulation significantly reduces neovascular glaucoma risk in patients with radiation-induced ocular ischemia. This treatment offers a promising strategy for preserving vision after radiotherapy for ocular melanoma.
Area of Science:
- Ophthalmology
- Radiation Oncology
- Oncology
Background:
- Radiation-induced ocular ischemia is a serious complication following radiotherapy for choroidal or ciliary body melanoma.
- Neovascular glaucoma is a severe consequence of ocular ischemia, leading to vision loss.
Purpose of the Study:
- To evaluate the effectiveness of panretinal photocoagulation in preventing neovascular glaucoma in patients with radiation-induced ocular ischemia.
- To assess the impact of early intervention with panretinal photocoagulation on glaucoma development.
Main Methods:
- A non-randomized study of 20 patients with radiation-induced ocular ischemia post-cobalt-60 plaque radiotherapy.
- Eleven patients received panretinal photocoagulation; nine served as an untreated control group.
Main Results:
- The incidence of neovascular glaucoma was significantly lower in the photocoagulated group compared to the untreated group (p = 0.024).
- Preliminary findings suggest a protective effect of panretinal photocoagulation.
Conclusions:
- Panretinal photocoagulation appears to be an effective prophylactic measure against neovascular glaucoma in radiation-induced ocular ischemia.
- Early photocoagulation may be a valuable strategy to prevent vision-threatening complications after ocular radiotherapy.